Ryman Healthcare Ltd
RYM: XNZE (NZL)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
NZD 6.60 | Fhkwqt | Sxflgrhzg |
Ryman Healthcare Remains Well Placed To Benefit From an Expanding Elderly Cohort
Business Strategy and Outlook
Ryman is New Zealand’s largest retirement village operator, controlling about 18% of a fragmented market. It typically combines retirement and aged care facilities, allowing residents to transition from independent to supported living. In addition to a reputation for quality, we believe the integrated model is a benefit that existing competitors would struggle to replicate, due to the costs of retrofitting existing nonintegrated facilities. We believe Ryman Healthcare remains well-positioned to achieve double-digit earnings growth during the next 10 years, driven by strong fundamentals in the aged-care sector.